Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEP1B | Q16820 | 1/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.33 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15065240 | 0.93 | MEP1B (0.38) | MEP1BTAS1R3TAS1R1TAS1R2ALDH1A1 | |
| SCHEMBL15083039 | 0.81 | ALDH1A1 (0.41) | MEP1BTAS1R3TAS1R1TAS1R2ALDH1A1 | |
| SCHEMBL718784 | 0.77 | ALDH1A1 (0.43) | MEP1BTAS1R3TAS1R1TAS1R2ALDH1A1 | |
| SCHEMBL29951760 | 0.77 | ALDH1A1 (0.43) | MEP1BTAS1R3TAS1R1TAS1R2ALDH1A1 | |
| SCHEMBL11903215 | 0.76 | MEP1B (0.34) | MEP1BALDH1A1KDM4EHSD17B10 | |
| SCHEMBL14665871 | 0.75 | ALDH1A1 (0.41) | MEP1BTAS1R3TAS1R1TAS1R2ALDH1A1 | |
| SCHEMBL19209983 | 0.71 | MEP1B (0.34) | MEP1BTAS1R3TAS1R1TAS1R2ALDH1A1 | |
| SCHEMBL14665872 | 0.70 | ALDH1A1 (0.38) | MEP1BTAS1R3TAS1R1TAS1R2ALDH1A1 | |
| SCHEMBL5953023 | 0.67 | PTPN1 (0.31) | — | |
| SCHEMBL15331758 | 0.67 | L3MBTL1 (0.33) | MEP1BTAS1R3TAS1R1TAS1R2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | SYNGENTA LIMITED (US) | 2012-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202690-A1 | HERBICIDAL COMPOUNDS | DDT, HAO2, HAAO | MEP1B 2906/4885TAS1R3 4361/4885TAS1R1 4355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.